Hepatitis, Chronic: all 829 studies
Page 1 of 9. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe RegionsRecruitingNCT07654283Phase 2
- Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific RegionRecruitingNCT07370207Phase 2
- A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis BRecruitingNCT07200193Phase 1/2
- A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis BNot yet recruitingNCT06926647
- Effects of Peginterferon Consolidation Therapy on Hepatic cccDNA Dynamics in CHB Patients Achieving Clinical Cure.Not yet recruitingNCT06920329Not applicable
- New HBV Infection Biomarkers: Clinical Characterization and Impact on ManagementRecruitingNCT06906016
- Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAgNot yet recruitingNCT06900166Phase 4
- Non-Invasive Model for Fibrosis Regression in HBV PatientsRecruitingNCT06874127
- Research on Clinical Recovery and Maintenance Strategies for CHBRecruitingNCT06803368Not applicable
- Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in AdultsEnrolling by invitationNCT06777173Not applicable
- An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis BNot yet recruitingNCT06745973Early Phase 1
- A Follow-up Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis BEnrolling by invitationNCT06707922Not applicable
- Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting InterferonRecruitingNCT06696664
- Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis BRecruitingNCT06671093Phase 1
- Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B PatientsNot yet recruitingNCT06661148Phase 1
- Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHBNot yet recruitingNCT06616103
- A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis BRecruitingNCT06566248Phase 2
- Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB PatientsRecruitingNCT06457477Not applicable
- Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）RecruitingNCT06368882Phase 4
- Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）RecruitingNCT06323681Not applicable
- From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B PatientsRecruitingNCT06295328Phase 1/2
- Impact of Hepatitis B Virus Genotype on Treatment Response in Children With Chronic Hepatitis BRecruitingNCT06289725
- A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis BRecruitingNCT06263959Phase 2
- Find HDV and Determine Its Status in TurkeyRecruitingNCT06248580
- Characteristics and Risk Factors for Invasive Fungal Infection With Acute-on-chronic Hepatitis B Liver FailureNot yet recruitingNCT06190002
- Population-wide Research for HBV-related Liver Diseases in Maoming CityNot yet recruitingNCT06184347
- Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D PatientsRecruitingNCT06051045
- A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis BNot yet recruitingNCT06041022
- Dynamic Changes of Serum HBV RNA in Chronic Hepatitis B PatientsNot yet recruitingNCT05991531
- Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.Enrolling by invitationNCT05956379Not applicable
- Clinical Efficacy and Safety of Tenofovir Disoproxil Fumarate and Entcavir in Treatment of Chronic Hepatitis B Patients in Upper EgyptRecruitingNCT05874440
- Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis BRecruitingNCT05808374Phase 1
- A Study to Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug)RecruitingNCT05808335Phase 2
- Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLDRecruitingNCT05766449
- The Effect of Metabolic Syndrome on Antiviral Response in People With Chronic Hepatitis BNot yet recruitingNCT05705141
- Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate PhaseRecruitingNCT05661786
- Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With CancerRecruitingNCT05181826
- The Effectiveness and Safety of Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Patients With Mildly Elevated Alanine Aminotransferase and Significant Liver Injury.RecruitingNCT04674423Phase 4
- VACcination of LIver Transplantation CandidatesRecruitingNCT04446832
- The Establishment of Korean Hepatitis B Patients CohortRecruitingNCT04139850
- Real World Study of Chronic Viral HepatitisRecruitingNCT04025944
- Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)RecruitingNCT03792919Phase 4
- Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis bRecruitingNCT02883647
- Evaluation of Patients With Liver DiseaseRecruitingNCT00001971
- A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B InfectionTerminatedNCT04820686Phase 2Results posted
- A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus InfectionTerminatedNCT04781647Phase 2Results posted
- Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB)CompletedNCT04676724Phase 2Results posted
- A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse Transcriptase InhibitorsTerminatedNCT04454567Phase 2Results posted
- A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB)CompletedNCT04449029Phase 2Results posted
- Study of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus InfectionCompletedNCT04423393Phase 1Results posted
- A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus InfectionTerminatedNCT04398134Phase 2Results posted
- Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis BCompletedNCT03905655Phase 2Results posted
- Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)CompletedNCT03852433Phase 2Results posted
- A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B PatientsTerminatedNCT03780543Phase 2Results posted
- Study of VIR-2218 in Healthy Subjects and Patients With Chronic Hepatitis BCompletedNCT03672188Phase 1/2Results posted
- Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on TreatmentCompletedNCT03615066Phase 2Results posted
- A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV)CompletedNCT03577171Phase 2Results posted
- A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B InfectionCompletedNCT03576066Phase 2Results posted
- A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis DCompletedNCT03546621Phase 2Results posted
- Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)CompletedNCT03501550Phase 2Results posted
- Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis BCompletedNCT03491553Phase 2Results posted
- Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) InfectionTerminatedNCT03487848Phase 2Results posted
- Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)TerminatedNCT03434353Phase 2Results posted
- A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis BCompletedNCT03258710Phase 4Results posted
- Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-InfectionCompletedNCT03235349Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-InfectionCompletedNCT03222583Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 InfectionCompletedNCT03219216Phase 3Results posted
- Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)CompletedNCT03180619Phase 2Results posted
- A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated CirrhosisCompletedNCT03089944Phase 3Results posted
- 'Fibrosis in the Lost Hepatitis C Population - Track, Trace and Treat'CompletedNCT03088917Results posted
- A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal ImpairmentCompletedNCT03069365Phase 3Results posted
- A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT03067129Phase 2/3Results posted
- Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian FederationCompletedNCT03053180Results posted
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis BCompletedNCT03038113Phase 1Results posted
- Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal DiseaseCompletedNCT03036852Phase 2Results posted
- A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) SubjectsCompletedNCT03020745Phase 2Results posted
- Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC TaiwanCompletedNCT03020095Phase 2Results posted
- Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China IIICompletedNCT03020082Phase 3Results posted
- Efficacy and Safety of Danoprevir/r + PR 12-week Triple Therapy in Treatment-Naive, Non-Cirrhotic, G1 CHC China IICompletedNCT03020004Phase 2Results posted
- Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)CompletedNCT03002818Results posted
- Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically SuppressedCompletedNCT02979613Phase 3Results posted
- Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis CTerminatedNCT02971033Phase 2Results posted
- Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis BCompletedNCT02881008Phase 1/2Results posted
- Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver TransplantCompletedNCT02862548Phase 2Results posted
- Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis BCompletedNCT02862106Phase 2Results posted
- Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in ColombiaCompletedNCT02851069Results posted
- VBMI to Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis CCompletedNCT02823457Not applicableResults posted
- Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis CCompletedNCT02817594Results posted
- Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in RomaniaCompletedNCT02807402Results posted
- Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis CCompletedNCT02803138Results posted
- Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational StudyCompletedNCT02798315Results posted
- A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)CompletedNCT02738138Phase 3Results posted
- Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis CCompletedNCT02725866Results posted
- A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus InfectionCompletedNCT02723084Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus InfectionCompletedNCT02707952Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)CompletedNCT02692703Phase 3Results posted
- Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian FederationCompletedNCT02669940Results posted
- A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 InfectionCompletedNCT02651194Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated CirrhosisCompletedNCT02642432Phase 3Results posted
- Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis CCompletedNCT02640547Results posted